Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Amortization of Deferred Charges (2018 - 2025)

Exagen (XGN) has disclosed Amortization of Deferred Charges for 8 consecutive years, with $131000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Amortization of Deferred Charges rose 211.9% year-over-year to $131000.0, compared with a TTM value of $378000.0 through Dec 2025, up 145.45%, and an annual FY2025 reading of $378000.0, up 145.45% over the prior year.
  • Amortization of Deferred Charges was $131000.0 for Q4 2025 at Exagen, up from $126000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $333000.0 in Q3 2022 and bottomed at -$57000.0 in Q2 2022.
  • Average Amortization of Deferred Charges over 5 years is $88950.0, with a median of $97000.0 recorded in 2024.
  • The sharpest move saw Amortization of Deferred Charges plummeted 142.54% in 2022, then soared 430.0% in 2025.
  • Year by year, Amortization of Deferred Charges stood at $137000.0 in 2021, then grew by 2.19% to $140000.0 in 2022, then plummeted by 73.57% to $37000.0 in 2023, then grew by 13.51% to $42000.0 in 2024, then surged by 211.9% to $131000.0 in 2025.
  • Business Quant data shows Amortization of Deferred Charges for XGN at $131000.0 in Q4 2025, $126000.0 in Q3 2025, and $53000.0 in Q2 2025.